SEER

Seer, Inc.

Seek Inc. is a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that can make them a reality. The Company\'s Proteograph is an integrated solution consisting of consumables, automation instrumentation and proprietary software that performs deep, unbiased proteomics analysis at scale in a matter of hours. The Company\'s designed the Proteograph to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution broadly available to life sciences researchers.

Seer, Inc. (SEER) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B (3.3) C (2.2) B (3.3) B- (2.9) C+ (2.6) B- (2.9)
2026-11-07 B (3.4) C- (1.9) C+ (2.8) C+ (2.8) C+ (2.7) C+ (2.7)
2026-10-31 B (3.3) D+ (1.8) C+ (2.8) C+ (2.6) C+ (2.7) C+ (2.6)
2026-10-24 B (3.3) D+ (1.8) C+ (2.8) C+ (2.5) C+ (2.6) C+ (2.6)

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe